Home Picks Investors Groups Discuss! Research

Search

Sign Up   |   Log In   |   What is SocialPicks?

Street Insider Return Risk +0.33% MID Tracked Blogger Profile & Performance Subscribe to author

Symbol Sentiment Start Return Closed NOVN n/a Via StreetInsider.com News Articles:   Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) and Hisamitsu Pharmaceutical Co., Inc. have entered into a definitive merger agreement pursuant to which Hisamitsu has proposed to acquire Noven for total cash consideration of approximately $428 million, or $16.50 per share, in an all-cash tender offer for 100% of the outstanding shares of Noven. The offer price represents a 22% premium to the closing price of Noven's common stock on July 13, 2009, and a 43% premium to Noven's average closing price for the preceding 90 days. The acquisition is expected to be effectuated through a cash tender offer by a wholly-owned subsidiary   Read the rest of original post »

Be the first to comment on this story and earn 2 points.

IN THE PRESS

About  |   RSS  |   Feedback  |   Contact Us  |   Terms of Service  |   Privacy

© 2009 FinancialContent Services, Inc.

Data powered by FinancialContent.  All Rights Reserved.   Quotes delayed at least 20 minutes unless otherwise indicated.

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.